Skip to content
Gaming Evolution Unveiled — Unveil Today's Hottest Gaming Trends! — Stay Informed on Latest Trends — laliga

NOWEDA tests zero-emission Opel Vivaro-e for pharmaceutical deliveries

Can hydrogen and electric vans revolutionize medical logistics? NOWEDA puts Opel's zero-emission transporters to the test in real-world pharmaceutical deliveries.

,   and  Administrator
1 min read
The image shows a hydrogen fuel cell electric vehicle, with its various parts labeled. It is a...
The image shows a hydrogen fuel cell electric vehicle, with its various parts labeled. It is a sleek, modern car with a glossy black finish, and the text on the image reads "Hydrogen Fuel Cell Electric Vehicle". The car is surrounded by a bright yellow background, giving it a vibrant and eye-catching look. The components of the car are clearly visible, including the battery, fuel tank, and other electrical components.

NOWEDA tests zero-emission Opel Vivaro-e for pharmaceutical deliveries

NOWEDA, a pharmaceutical logistics provider, has taken delivery of two Opel Vivaro-e transporters—one battery-electric and one hydrogen-powered. The vehicles will be tested for locally emission-free deliveries of temperature-sensitive medical products. The handover took place at NOWEDA's headquarters in Essen.

Andreas Kunkat, Head of Key Accounts at Stellantis Germany, officially presented the vehicles to NOWEDA. Both models were specially adapted by Opel alongside conversion specialists CSA ClimaVan Solutions Automotive and Fahrzeugbau Dülmer to meet Good Distribution Practice (GDP) standards for pharmaceutical transport.

The battery-electric Vivaro-e offers a range of up to 328 kilometres with its larger battery, or 229 kilometres with the 50 kWh version. It provides up to 6.1 cubic metres of cargo space, ensuring ample room for medical shipments.

The Vivaro-e Hydrogen, equipped with a fuel cell system, extends the range further to over 400 kilometres on a full tank. Refuelling takes just three minutes, making it a practical option for long-distance logistics. Both transporters will now undergo real-world testing to prove their suitability for GDP-compliant deliveries.

As of early 2026, large-scale commercial use of hydrogen-powered vehicles for temperature-controlled pharmaceutical transport in Germany remains rare. While some pilot projects and feasibility studies have been carried out, no major established fleet operations in this niche have yet entered regular service.

The deployment of these vehicles marks a step toward emission-free pharmaceutical logistics. NOWEDA will assess their performance in daily operations, focusing on efficiency and compliance with GDP requirements. The results could influence future adoption of similar transport solutions in the industry.

Read also:

Related

Latest